Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A molecular signature in blood identifies early Parkinson's disease.

Molochnikov L, Rabey JM, Dobronevsky E, Bonucelli U, Ceravolo R, Frosini D, Grünblatt E, Riederer P, Jacob C, Aharon-Peretz J, Bashenko Y, Youdim MB, Mandel SA.

Mol Neurodegener. 2012 May 31;7:26. doi: 10.1186/1750-1326-7-26.

3.

Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease.

Grünblatt E, Zehetmayer S, Jacob CP, Müller T, Jost WH, Riederer P.

J Neural Transm (Vienna). 2010 Dec;117(12):1387-93. doi: 10.1007/s00702-010-0509-1. Epub 2010 Nov 11.

PMID:
21069393
4.

Found in transcription: accurate Parkinson's disease classification in peripheral blood.

Karlsson MK, Sharma P, Aasly J, Toft M, Skogar O, Sæbø S, Lönneborg A.

J Parkinsons Dis. 2013;3(1):19-29. doi: 10.3233/JPD-120159.

PMID:
23938308
5.

Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.

DeMarshall CA, Han M, Nagele EP, Sarkar A, Acharya NK, Godsey G, Goldwaser EL, Kosciuk M, Thayasivam U, Belinka B, Nagele RG; Parkinson’s Study Group Investigators..

Immunol Lett. 2015 Nov;168(1):80-8. doi: 10.1016/j.imlet.2015.09.010. Epub 2015 Sep 16.

6.

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.

Mollenhauer B, Trautmann E, Sixel-Döring F, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Focke NK, Kumar KR, Lohmann K, Klein C, Schlossmacher MG, Kohnen R, Friede T, Trenkwalder C; DeNoPa Study Group..

Neurology. 2013 Oct 1;81(14):1226-34. doi: 10.1212/WNL.0b013e3182a6cbd5. Epub 2013 Aug 30.

PMID:
23997153
7.

Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease.

Tang G, Zhang M, Xie H, Jiang S, Wang Z, Xu L, Hao Y, Lin D, Lan H, Wang Y, Chen L, Ren D.

Neurosci Lett. 2002 Aug 9;328(2):195-7.

PMID:
12133586
8.

Abnormal serum concentrations of proteins in Parkinson's disease.

Goldknopf IL, Bryson JK, Strelets I, Quintero S, Sheta EA, Mosqueda M, Park HR, Appel SH, Shill H, Sabbagh M, Chase B, Kaldjian E, Markopoulou K.

Biochem Biophys Res Commun. 2009 Nov 13;389(2):321-7. doi: 10.1016/j.bbrc.2009.08.150. Epub 2009 Aug 31.

PMID:
19723509
9.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042
10.

Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.

Chung SJ, Jung Y, Hong M, Kim MJ, You S, Kim YJ, Kim J, Song K.

Neurobiol Aging. 2013 Nov;34(11):2695.e1-7. doi: 10.1016/j.neurobiolaging.2013.05.022. Epub 2013 Jun 29.

PMID:
23820587
11.

Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription--potential to delay Parkinson's disease.

Lauterbach EC.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:236-9. doi: 10.1016/j.pnpbp.2012.08.021. Epub 2012 Oct 7.

PMID:
23046827
12.

A gene expression pattern in blood for the early detection of Alzheimer's disease.

Booij BB, Lindahl T, Wetterberg P, Skaane NV, Sæbø S, Feten G, Rye PD, Kristiansen LI, Hagen N, Jensen M, Bårdsen K, Winblad B, Sharma P, Lönneborg A.

J Alzheimers Dis. 2011;23(1):109-19. doi: 10.3233/JAD-2010-101518.

PMID:
20930264
13.

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Ioannidis JP, Singleton AB; Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators..

Lancet Neurol. 2015 Oct;14(10):1002-9. doi: 10.1016/S1474-4422(15)00178-7. Epub 2015 Aug 10.

14.
15.

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.

Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM.

Neurology. 2009 Apr 21;72(16):1378-84. doi: 10.1212/01.wnl.0000340982.01727.6e. Epub 2009 Jan 7. Erratum in: Neurology. 2009 Jun 9;72(23):2059.

16.

Molecular markers of early Parkinson's disease based on gene expression in blood.

Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):955-60. Epub 2007 Jan 10.

17.

Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera.

Han M, Nagele E, DeMarshall C, Acharya N, Nagele R.

PLoS One. 2012;7(2):e32383. doi: 10.1371/journal.pone.0032383. Epub 2012 Feb 22.

18.

Biomarkers for the early detection of Parkinson's and Alzheimer's disease.

Berg D.

Neurodegener Dis. 2008;5(3-4):133-6. doi: 10.1159/000113682. Epub 2008 Mar 6. Review.

PMID:
18322370
19.

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J.

Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.

PMID:
22890010
20.

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.

Chiba-Falek O, Lopez GJ, Nussbaum RL.

Mov Disord. 2006 Oct;21(10):1703-8.

PMID:
16795004

Supplemental Content

Support Center